Treatment in basic attention of leshimaniosis with intralesional application of glucantime in face region
DOI:
https://doi.org/10.36489/saudecoletiva.2021v11i68p7441-7450Keywords:
Leishmaniasis, Wounds and Injuries, Meglumine AntimoniateAbstract
American cutaneous leishmaniasis is an endemic infectious disease in the country's public health. The disease is transmitted after the bite of females of the hematophagous mosquito, known as sand fly, and has several clinical manifestations, classified as cutaneous, cutaneous-mucosal and diffuse cutaneous, affecting all genders and age groups. The aim of this article is to report the clinical case of a patient, presenting an ulcerated lesion in the region of the face. The method used was the identification of Leishmania through the polymerase chain reaction associated with clinical response to treatment after intralesional application. As a result, immediate responses were obtained from the lesions that, despite studies showing spontaneous healing after months/years, facial lesions need a more aggressive protocol. It is concluded that the importance of the report is due to the fact that the therapeutic treatment consists of direct application in a location not authorized by the protocol of the Ministry of Health for American tegumentary leishmaniasis.